ADMA News and Press, ADMA Biologics Inc From 03/23/23

2023-03-23 22:10:03 ET ADMA Biologics, Inc. (ADMA) Q4 2022 Earnings Conference Call March 23, 2023, 16:30 ET Company Participants Skyler Bloom - Senior Director of Business Development & Corporate Strategy Adam Grossman - Co-Founder, President, CEO & Director...

2023-03-23 17:33:55 ET ADMA Biologics ( NASDAQ: ADMA ) said it is expecting to generate positive EBITDA by the second half of 2023. The company also said it projects 2023 revenues to surpass $210M. Consensus is $211.04M. In 2024, ADMA ( ADMA ) is estimating top-lin...

2023-03-23 17:01:12 ET Gainers: Pyxis Oncology ( PYXS ) +15% . CRISPR Therapeutics ( CRSP ) +11% . ADMA Biologics ( ADMA ) +6% . Harrow Health ( HROW ) +4% . Solid Power ( SLDP ) +5% . Losers: Scholastic ( SCHL ) -1...

2023-03-23 16:06:59 ET ADMA Biologics press release ( NASDAQ: ADMA ): Q4 GAAP EPS of -$0.06 beats by $0.01 . Revenue of $49.95M (+89.3% Y/Y) beats by $1.88M . The revenue growth for the fourth quarter of 2022, compared to the fourth quarter of 2021, was favorab...

4Q2022 Total Revenues of $50 Million, a 90% Y-o-Y Increase 4Q2022 Gross Profit of $14 Million, an $11 Million Y-o-Y Increase FY 2023 Total Revenue Expected to Exceed $210 Million First-Time Positive EBITDA Expected No Later than Second Half of 2023 Conference Cal...

2023-03-22 17:35:56 ET ADMA Biologics ( NASDAQ: ADMA ) is scheduled to announce Q4 earnings results on Thursday, March 23rd, after market close. The consensus EPS Estimate is -$0.07 (+22.2% Y/Y) and the consensus Revenue Estimate is $48.07M (+82.2% Y/Y). Over the last ...

RAMSEY, N.J. and BOCA RATON, Fla., March 16, 2023 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biolog...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s super-easy to look for large-cap stocks – those names that seemingly everyone knows, or FAANG stocks that get plenty of attention from both analysts and retail investors. But if you want to stand out from t...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you’re not investing in healthcare stocks these days, you may be missing out on a huge opportunity. Consider this: We are getting older and living longer as a species. The World Health Organization says that by ...

ADMA Biologics ( NASDAQ: ADMA ) it had received U.S. Food and Drug Administration approval for its eighth ADMA BioCenters plasma collection facility located in Hammond. The facility is now licensed to collect, and introduce into interstate commerce, human source plasma for furthe...